Novo Nordisk awards Emerson $40M automation contract for new US plant

Novo Nordisk awarded Emerson a $40 million automation systems and services contract for its new $2 billion drug manufacturing facility in Clayton, North Carolina, targeting operational readiness by 2020.

“Our extensive experience in the life sciences industry and integrated offering for capital projects and automation perfectly positions us to help Novo Nordisk deliver its largest project in history.”biospace.com

• 2 sources
• biospace.comNovo Nordisk Selects Emerson to Help Bring Medication to Market More Quickly to Address Growing Diabetes Epidemic - BioSpaceAnnalee ArmstrongNov 13, 2017
• drugdiscoverytrends.comNovo Nordisk Awards $40M Automation Contract For New U.S. Manufacturing Facility - Drug Discovery and DevelopmentNovo Nordisk A/SNov 15, 2017

Summarized from public sources; check the original articles before acting on it.